TTK Healthcare Sells EVA and Good Home Brands to Wipro Enterprises for Rs 256 Crores
TTK Healthcare Ltd has entered into a definitive agreement for the sale of its 'EVA' and 'Good Home' brands. The transaction involves M/s Wipro Enterprises Private Limited as the buyer, with the completion contingent upon customary conditions precedent in such deals.The deal signifies the divestment of two brand units from TTK Healthcare Ltd. The consideration for this acquisition is set at Rs 256 crores plus applicable GST.
According to details provided regarding the transaction, the brands sold—'EVA' and 'Good Home'—had generated substantial revenue for the company in the last financial year. For FY 2025-26, the Revenue / Turnover / Income from these two brands stood at Rs 148 crores, which represented 17% of the total turnover of TTK Healthcare Ltd.
The transaction does not involve any related parties or fall under a slump sale category.
A summary of the key financial and timeline details of the brand sale is presented below:
| Financial Metric | Details |
|---|---|
| Brands Sold | EVA and Good Home |
| Buyer Name | M/s Wipro Enterprises Private Limited |
| Date of Agreement | July 23, 2026 |
| Total Consideration | Rs 256 crores plus applicable GST |
| FY 2025-26 Revenue Share | Rs 148 crores (17% of total company turnover) |
| Expected Completion Date | September 30, 2026 |
The buyer, M/s Wipro Enterprises Private Limited, is not affiliated with the Promoter Group of TTK Healthcare Ltd. The transaction has been confirmed as an arm's length deal and does not fall under related party transactions.
The completion of the sale remains subject to the fulfillment of all conditions precedent standard in such mergers and acquisitions.
TTKHLTCARE Stock Price Movement
As live trading stands at 12:57 PM, TTK Healthcare Limited shares are rallying to ₹1034.9, driven by a strong 2.87% gain today. The stock is currently active on a volume of 8,897 shares, maintaining bullish momentum during the ongoing market session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.